Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. (Q45071199)
Jump to navigation
Jump to search
scientific article published on 29 June 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer. |
scientific article published on 29 June 2017 |
Statements
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer (English)
Li Yan
Masayuki Nagahashi
Ali Raza
Debra E Lyon
1 reference
1 reference